Search:

Login | Subscribe

Home > Companies > Norwood Immunology

Price	Market	Sector	Market Cap
2.38p (0.00p) 0.00%	AIM	Health Care and Related Services	£5.43m

Add to company folder | Print

Related Companies

FDT	4.25p	0.00%
AMS	32.25p	0.00%
AKR	8.00p	1.59%
AOR	182.50p	0.00%
AVG	47.50p	0.00%
BNX	p
CTN	20.00p	2.56%
CUS	0.88p	0.00%
DSY	2.00p	14.29%
DEMG	12.25p	13.95%
GTX	41.50p	0.00%
HCEG	0.36p	0.00%
IDH	198.00p	0.00%
LID	7.75p	0.00%
MDW	4.88p	0.00%
BPRG	p
NMT	p
OSH	p
PKL	p
SUN	1.00p	0.00%
MLH	16.75p	0.00%
TSL	p

Commentary

Focused on the rejuvenation of the immune system and the development of virosomal vaccines

Recent Articles

Norwood Immunology loses £2.3m	13/10/2005
Drug floats drying up	02/08/2004
Tech watch - by Elliott Davis	02/06/2004

Recent Announcements

Exclusive Evaluation Agreemen	16/07/2008
Interim Results	31/03/2008
Board Change and Update	21/12/2007
Preliminary Results	30/10/2007
Interim Results	30/03/2007

Articles from the Sector

Hospital deal buoys Deltex	03/12/2008
MediLink Global UK seeks China growth	14/11/2008
Celsis ‘on track’	12/11/2008
Southern Cross completes refinancing	31/10/2008
‘Progress’ at CareTech	15/10/2008
Southern Cross still selling	09/10/2008
Assura in £80m funding	07/10/2008
Tristel	06/10/2008
Silver lining at AMS	06/10/2008
Medicsight	14/08/2008
More

Financial History

Financial Year End	30/06/2003	30/06/2004	30/06/2005	30/06/2006	30/06/2007
Currency	AUD	AUD	AUD	AUD	AUD
Turnover	0.00	0.00	0.00	0.00	0.00
Operating Profit	-5.95	-8.14	-5.23	-6.67	-4.66
Pretax Profit	-5.95	-8.12	-5.23	-6.71	-4.86
Earnings After Tax	-5.95	-8.12	-5.23	-6.71	-4.86
Profit Available For Dividend	0.00	0.00	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00	0.00	0.00
Retained Profit	-5.95	-8.12	0.00	0.00	0.00
Shareholders Funds	-5.76	8.79	10.15	3.14	28.89
Net Current Assets	-5.76	8.79	0.00	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	0.00	0.04	0.00	0.00
Adj Earnings Per Share	0.00	0.00	0.04	0.00	0.00
Dividend Per Share	0.00	0.00	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address	Level 1, 322 Glenferrie Road, Victoria, 3144
Telephone
Fax
Executives
Chairman	Peter Hansen (0.00% holding)
Chief Executive	Richard Williams (0.00% holding)
Finance Director	(0.00% holding)
Non-Exec Director	Jeffrey Bell (0.00% holding)
Main Shareholders
	Norwood Abbey: 39.5% OppenheimerFunds: 12.1% Tiedemann: 10.7%
Advisers
Nominated Adviser	KBC Peel Hunt
Nominated Broker	KBC Peel Hunt
Solicitors	Minter Ellison
Auditors	Deloitte
Registrar	Computershare Investor Services

Commentary
Focused on the rejuvenation of the immune system and the development of virosomal vaccines
Company Data
Code	NIM
Sedol	AU000A0CAN
Shares In Issue	228.241 m
Indices
Entry on AIM	30/06/2004
Interim Results	Mar
Final Results	Oct
Year End	Jun
Accounts Due	Oct
Int div payment	n/a
Fin div payment	n/a
Int net div per share	nil
Fin net div per share	nil
Probable CGT relief